James Lee
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 5
-
- RNA Research and Splicing 2
- Co-authors
- Michel Sadelain (3 shared papers)Renier J. Brentjens (4 shared papers)Erik Hayman (2 shared papers)Hollie J. Pegram (2 shared papers)Gavin H. Imperato (1 shared paper)Thomas F. Tedder (1 shared paper)Jeffrey A. Bluestone (4 shared papers)Arabella Young (3 shared papers)
- Journals
- The Journal of Immunology (2 papers)Nature Communications (1 paper)Science Immunology (1 paper)Blood (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
James Lee
23 papers receiving 2.3k citations
James Lee's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.3k
- Immunology 658
- Nephrology 109
- Genetics 406
- Cancer Research 187
Countries citing papers authored by James Lee
This map shows the geographic impact of James Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lee more than expected).
Fields of papers citing papers by James Lee
This network shows the impact of papers produced by James Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lee. The network helps show where James Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside James Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning Hit paper breakdown → | 2012 | 559 |
| 2 | Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors Hit paper breakdown → | 2018 | 433 |
| 3 | 2020 | 212 | |
| 4 | 1999 | 200 | |
| 5 | 2009 | 172 | |
| 6 | 2013 | 116 | |
| 7 | 2007 | 112 | |
| 8 | 2009 | 98 | |
| 9 | 2021 | 92 | |
| 10 | 2021 | 85 | |
| 11 | 2011 | 80 | |
| 12 | 2018 | 58 | |
| 13 | Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. | 2002 | 29 |
| 14 | 2013 | 21 | |
| 15 | 2019 | 19 | |
| 16 | 2013 | 15 | |
| 17 | Supplementary Materials for Kinome siRNA Screen Identifies Regulators of Ciliogenesis and Hedgehog Signal Transduction | 2008 | 13 |
| 18 | 2007 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2024 | 6 |
About James Lee
James Lee is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Cell Biology, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Genomics and Diagnostics (2 papers), Microtubule and mitosis dynamics (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (658 citations), Nephrology (109 citations), Genetics (406 citations) and Cancer Research (187 citations). James Lee has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Michel Sadelain, Renier J. Brentjens, Erik Hayman, Hollie J. Pegram, Gavin H. Imperato, Thomas F. Tedder, Jeffrey A. Bluestone, Arabella Young, Adil Daud and Vishva M. Dixit. Their work appears in journals such as The Journal of Immunology, Nature Communications, Science Immunology, Blood and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.